Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
17.23
+0.48 (2.87%)
At close: Jul 2, 2026, 4:00 PM EDT
16.31
-0.92 (-5.34%)
After-hours: Jul 2, 2026, 7:33 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $16.85 million as of July 2, 2026. Its market cap has decreased by -72.75% in one year.
Market Cap
16.85M
Enterprise Value
-906.72K
1-Year Change
-72.75%
Ranking
Category
Stock Price
$17.23
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $16.85M, a decrease of -98.03%. That is a compound annual growth rate of -42.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 16.85M | -90.97% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 18.27M |
| Atossa Therapeutics | 18.26M |
| Akari Therapeutics, | 18.22M |
| Celularity | 17.94M |
| GT Biopharma | 17.01M |
| Moolec Science | 16.57M |
| Werewolf Therapeutics | 16.54M |
| Chemomab Therapeutics | 16.34M |